Antioxidants and methimazole in the treatment of Graves' disease: Effect on urinary malondialdehyde levels

We have postulated that metabolic oxidation could be the source of signs and symptoms of hyperthyroidism. The present study was designed to evaluate urinary malondialdehyde levels in Graves' disease and compare this oxidative stress biomarker with the clinical evolution of patients suffering th...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Guerra, Liliana Noemí, Ríos de Molina, María del Carmen, Miler, Eliana Andrea
Publicado: 2005
Materias:
Acceso en línea:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00098981_v352_n1-2_p115_Guerra
http://hdl.handle.net/20.500.12110/paper_00098981_v352_n1-2_p115_Guerra
Aporte de:

Ejemplares similares